Research Collaborations

News Research Collaborations

• The UCB-Harvard Research Alliance Expands and Moves Forward

  UCB announced that it has launched a second collaborative research project with Harvard that builds upon the Research Alliance signed between UCB and Harvard in 2011. The second research project comprises a collaboration with the laboratory of Junying Yuan, Ph.D., Professor of Cell Biology at Harvar more

• Algeta and Sanofi extend research collaboration evaluating thorium-conjugated tumor-targeting antibody

  Algeta ASA announced that its research collaboration with Sanofi (previously Genzyme) has been extended. This collaboration, which was announced in April 2011, is focused on evaluating the potential of linking the alpha-emitter thorium-227 to a proprietary antibody from Genzyme to create a tumor-tar more

• From seaweed to biofuels

  Novozymes announced an exploratory research agreement with Sea6 Energy, an India-based company, to jointly develop a process for the production of biofuels from seaweed. The research alliance will use enzymes to convert seaweed-based carbohydrates to sugar, which can then be fermented to produce eth more

Publications Research Collaborations

• Aflatoxins, Fumonisins, and Trichothecenes: A Convergence of Knowledge

  Abstract Plant pathogenic fungi Aspergillus flavus, Fusarium verticillioides, and F. graminearum infect seeds of the most important food and feed crops, including maize, wheat, and barley. More importantly, these fungi produce aflatoxins, fumonisins and trichothecenes, respectively, which threat more

• Engaging Communities in Education and Research: PBRNs, AHEC, and CTSA

  Abstract Background: Community engagement has become a prominent element in medical research and is an important component of the Clinical and Translational Science Awards program. Area Health Education Centers engage communities in education and workforce development. Methods: Engaging Commun more

• The creation and progress of the J Project in Eastern and Central Europe

  Primary immunodeficiencies (PIDs) have now become recognized as a worldwide health problem. Rapid development of immunological and genetic technologies has led to the discovery of more than 200 PIDs and more than 150 disease‐related genes. Progress in the field is expected to take a new turn after more

Market studies Research Collaborations

• DiaMedica Inc. (DMA) - Financial and Strategic SWOT Analysis Review

  DiaMedica Inc. (DiaMedica) is a publicly held biopharmaceutical company principally involved in the discovery and development of pharmaceutical therapies and drugs for the treatment of type 2 diabetes. The company's key product candidates under development are used to reduce blood sugar and weight f more

• GeneNews Limited (GEN) - Financial and Strategic SWOT Analysis Review

  GeneNews Limited (GeneNews) is a Canada based molecular diagnostics company. Through its subsidiaries, it is principally engaged in developing blood-based biomarker tests for the early detection of diseases and personalized health management. The company also focuses on the application of functional more

• Millennium Pharmaceuticals, Inc. - Strategic SWOT Analysis Review

  Millennium Pharmaceuticals, Inc. (Millennium) is a biopharmaceutical company which is engaged in the research, development, and commercialization of medicines for the treatment of cancer in the US and across the globe. In May, 2008, Millennium was acquired by Takeda Pharmaceutical Company Limited. T more

Websites Research Collaborations